| MDL | MFCD31746873 |
|---|---|
| Molecular Weight | 413.42 |
| Molecular Formula | C21H23N3O6 |
| SMILES | O=C(N[C@@H](CO)C(N[C@@H](CC1=CC=CC=C1)C([C@]2(CO2)C)=O)=O)C(N3)=CC=CC3=O |
KZR-504 is a highly selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2) , with IC 50 s of 51 nM, 4.274 μM for LMP2 and LMP7, respectively. KZR-504 is of interest for the treatment of autoimmune disease [1] .
IC50: 51 nM (LMP2), 4.274 μM (LMP7) [1] .
Evaluating the inhibition of LMP2, and antitargets LMP7 and β5, in mouse tissues reveals that KZR-504 (compound 12) is both selective and potent in vivo with >50% target inhibition achieved at >1 mg/kg in all tissues tested except brain [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
-20°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
DMSO : 170 mg/mL ( 411.20 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.4188 mL | 12.0942 mL | 24.1885 mL |
| 5 mM | 0.4838 mL | 2.4188 mL | 4.8377 mL |
| 10 mM | 0.2419 mL | 1.2094 mL | 2.4188 mL |